The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale
NCT ID: NCT02976324
Last Updated: 2017-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2016-11-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
external diaphragmatic pacemaker group
use the external diaphragmatic pacemakerI 9 counts per minute, with stimulate frequency 40 Hz
external diaphragmatic pacemaker group
9 counts per minute, with stimulate frequency 40 Hz
control group
No inervention, just receive conventional therapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
external diaphragmatic pacemaker group
9 counts per minute, with stimulate frequency 40 Hz
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active tuberculosis
* install a cardiac pacemaker
* acute cardiocerebrovascular events: acute myocardial infarction, acute myocarditis, severe arrhythmia, severe cerebrovascular accidents.
* pregnancies
* end-stage patients (expected survival time less than 6 months)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhang Xiangyu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhang Xiangyu
Director of Intensive care medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
xiangyu zhang, doctor
Role: PRINCIPAL_INVESTIGATOR
Tongji University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EDPCCP2016
Identifier Type: -
Identifier Source: org_study_id